1-800-567-8911 or
604-682-5050
(Telephone interpreting in over 150 languages available)
|
Generic Name |
Common Trade Name(s) | Classification | Date Marketed in Canada (yyyy/mm/dd) |
|---|---|---|---|
| Regorafenib | Stivarga | Antineoplastic agent | 2013/03/11 |
| Ribociclib | Kisqali | Antineoplastic agent | 2018/11/26 |
| Rilpivirine | Edurant | Antiviral agent | 2011/08/08 |
| Risankizumab | Skyrizi | Interleukin-23 inihbitor | 2019/05/13 |
| Risedronate | Actonel DR | Bone metabolism regulator | 2011/09/28 |
| Risedronate + Calcium carbonate | Actonel APC | ||
| Risedronate sodium | Actonel | Bisphosphonate | |
| Roflumilast | Daxas | Phosphodiesterase 4 (PDE4) Inhibitor | 2010/11/25 |
| Romosozumab | Evenity | Bone formation agent | 2019/08/12 |
| Rosiglitazone + glimepiride | Avandaryl | 2011/03/31 | |
| Rotigotine | Neupro | Antiparkinsonian agent / Dopamine agonist | 2013/09/12 |
| Rufinamide | Banzel | Antiepileptic | 2011/09 |
| Rupatadine | Rupall | Antihistamine, second generation | 2017/01/25 |
| Ruxolitinib | Jakavi | Antineoplastic agent | 2012/07/18 |